Stock A195940 HK INNO.N CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings HK inno.N Corporation

Equities

A195940

KR7195940002

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 05/07/2024 am IST 		5-day change 1st Jan Change
36,150 KRW +0.42% Intraday chart for HK inno.N Corporation -3.60% -18.67%
19/06 IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments MT
04/04 Protium Science Co.,Ltd. announced that it has received KRW 2 billion in funding from HK inno.N Corporation CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company appears to be poorly valued given its net asset value.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company benefits from high valuations in earnings multiples.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
HK INNO.N CORPORATION Stock HK inno.N Corporation
-18.67% 742M -
MERCK KGAA Stock Merck KGaA
+5.34% 71.83B
A
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+23.57% 9.56B
A-
YUHAN CORPORATION Stock Yuhan Corporation
+30.09% 4.85B
B-
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-21.31% 4.48B
A-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+24.78% 3.9B -
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.03% 2.01B - -
INDIVIOR PLC Stock Indivior PLC
-1.10% 1.99B
B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-36.28% 1.89B
C-
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-43.19% 1.77B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. A195940 Stock
  4. Ratings HK inno.N Corporation